2.1 Clinical Indications & Physician Order Verification

2.1 Clinical Indications & Physician Order Verification

Polysomnography (PSG) is a complex, multi-channel diagnostic procedure that records electrophysiological, respiratory, and cardiac parameters during sleep. In clinical sleep medicine and on the Certified Polysomnographic Technician (CPSGT) examination, the technologist's primary responsibility begins before applying a single electrode: verifying the medical necessity of the test, auditing the physician's order for completeness and regulatory compliance, identifying clinical contraindications, and implementing customized patient safety accommodations.

According to the American Academy of Sleep Medicine (AASM) Practice Parameters and Clinical Guidelines, diagnostic testing must be tailored to specific clinical indications to ensure diagnostic accuracy and patient safety.

---

1. AASM Clinical Indications for Polysomnography

Polysomnography is not a generic screening tool for all sleep complaints; it is indicated when objective physiological data is required to diagnose, stratify, or guide treatment for specific sleep disorders.

+-----------------------------------------------------------------------------+
|                   AASM CLINICAL INDICATIONS FOR DIAGNOSTIC PSG              |
|                                                                             |
|   [SLEEP-RELATED BREATHING DISORDERS]                                       |
|   - Obstructive Sleep Apnea (OSA) in adults and children                    |
|   - Central Sleep Apnea (CSA) & Cheyne-Stokes Breathing Pattern (CSBP)     |
|   - Sleep-Related Hypoventilation / Hypoxemia (OHS, neuromuscular, COPD)   |
|                                                                             |
|   [CENTRAL DISORDERS OF HYPERSOMNOLENCE]                                    |
|   - Narcolepsy Type 1 and Type 2 (mandatory prior night baseline PSG)       |
|   - Idiopathic Hypersomnia (documenting >= 6-7 hours TST before MSLT)       |
|                                                                             |
|   [PARASOMNIAS & NOCTURNAL SEIZURE DISORDERS]                               |
|   - REM Sleep Behavior Disorder (RBD) — evaluating loss of REM atonia       |
|   - Violent, injurious, or atypical NREM Parasomnias (somnambulism, terrors)|
|   - Suspected Nocturnal Frontal Lobe Epilepsy (NFLE) / Nocturnal Seizures   |
|                                                                             |
|   [SLEEP-RELATED MOVEMENT DISORDERS]                                        |
|   - Suspected Periodic Limb Movement Disorder (PLMD)                        |
|   - Note: PSG is NOT indicated for typical, uncomplicated RLS alone         |
+-----------------------------------------------------------------------------+

A. Sleep-Related Breathing Disorders (SRBD)

• Obstructive Sleep Apnea (OSA): Medically indicated when patients exhibit cardinal symptoms (habitual loud snoring, witnessed apneas, nocturnal gasping/choking, excessive daytime sleepiness) or significant cardiovascular comorbidities (refractory hypertension, atrial fibrillation, stroke history, congestive heart failure).
• Central Sleep Apnea (CSA) & Cheyne-Stokes Breathing (CSB): Indicated in patients with heart failure, neurological stroke, or chronic high-dose opioid therapy presenting with shallow breathing, paroxysmal nocturnal dyspnea, or daytime somnolence.
• Sleep-Related Hypoventilation and Nocturnal Hypoxemia: Indicated for patients with neuromuscular disorders (e.g., ALS, muscular dystrophies), severe chest wall deformities (kyphoscoliosis), Obesity Hypoventilation Syndrome (OHS; BMI ≥ 30 kg/m² with awake hypercapnia $PaCO_2 \ge 45\text{ mmHg}$ them), or COPD-OSA overlap syndrome.

B. Central Disorders of Hypersomnolence

• Narcolepsy (Types 1 & 2) and Idiopathic Hypersomnia: An all-night diagnostic PSG is mandatory immediately preceding a daytime Multiple Sleep Latency Test (MSLT). The baseline PSG serves two vital purposes:
  1. It objectively confirms sufficient nocturnal sleep duration (at least 6 hours / 360 minutes of Total Sleep Time [TST]) to ensure daytime sleepiness is not simply artifactual sleep deprivation.
  2. It rules out untreated sleep apnea or severe sleep fragmentation that could invalidate the daytime sleep latency and Sleep Onset REM Periods (SOREMPs).

C. Parasomnias and Nocturnal Seizure Differentiations

• REM Sleep Behavior Disorder (RBD): Diagnostic PSG with expanded EMG derivations (chin EMG plus upper and lower extremity limb leads) is indicated to document REM Sleep Without Atonia (RSWA) and dream-enacting behaviors. RBD carries high diagnostic significance as a prodromal marker for alpha-synuclein neurodegenerative disorders (Parkinson's disease, Lewy body dementia, multiple system atrophy).
• Complex or Violent NREM Parasomnias: Sleepwalking (somnambulism), sleep terrors, and confusional arousals warrant PSG when behaviors are violent, injurious, potentially lethal, atypical in age of onset (beginning in adulthood), or medically refractory.
• Nocturnal Seizures vs. Parasomnias: When nocturnal paroxysms, stereotypic limb motor activity, or sudden explosive nocturnal awakenings occur, an expanded full 10-20 EEG montage combined with continuous synchronized time-locked infrared video polysomnography is indicated to differentiate Nocturnal Frontal Lobe Epilepsy (NFLE / Sleep-Related Hypermotor Epilepsy) from benign parasomnias.

D. Sleep-Related Movement Disorders

• Periodic Limb Movement Disorder (PLMD): Indicated when repetitive periodic limb kicks occur during sleep, causing documented sleep fragmentation, frequent electroencephalographic (EEG) arousals, and unexplained daytime hypersomnolence, in the absence of daytime Restless Legs Syndrome (RLS) symptoms.

E. Conditions Where Diagnostic PSG Is NOT Routinely Indicated

• Uncomplicated Chronic Insomnia: Insomnia is primarily a clinical diagnosis managed through Cognitive Behavioral Therapy for Insomnia (CBT-I). Routine PSG is not indicated unless the patient fails standard therapy or comorbid OSA/PLMD is suspected.
• Uncomplicated Restless Legs Syndrome (RLS): Diagnosed clinically via patient history (urge to move legs during rest relieved by movement, worsening in evening/night). PSG is unnecessary unless diagnostic ambiguity exists.
• Typical, Non-Violent Childhood Parasomnias: Benign sleep talking (somniloquy), occasional mild childhood sleepwalking, or standard nightmares do not require laboratory PSG.
• Circadian Rhythm Sleep-Wake Disorders: Primarily evaluated using actigraphy and sleep logs rather than overnight PSG, unless another intrinsic sleep disorder is suspected.

---

2. Physician Order Verification & Study Modalities

A sleep technologist cannot initiate a sleep recording without a complete, legally executed physician order. The technician must systematically audit the order to ensure all clinical and administrative parameters are met.

+-----------------------------------------------------------------------------+
|                   THE SIX ESSENTIAL ELEMENTS OF A PSG ORDER                 |
|                                                                             |
|   [1] Patient Identifiers  ---> Full Legal Name, DOB, MRN, Gender           |
|   [2] Study Type           ---> Diagnostic, Split-Night, Titration, MSLT   |
|   [3] Clinical Indication  ---> Documented Diagnosis with ICD-10 Code       |
|   [4] Provider Details     ---> Ordering Physician Name, NPI, Signature     |
|   [5] Special Parameters   ---> Supplemental O2, Extended EEG, TcCO2        |
|   [6] Titration Protocol   ---> CPAP/BiPAP guidelines, Mask type, Pressure  |
+-----------------------------------------------------------------------------+

Polysomnographic Study Types and Modalities:

Handling Incomplete or Discrepant Orders:

If an order lacks a physician signature, fails to specify the test modality (e.g., ordering "Sleep Study" without specifying baseline vs. split-night), lacks an ICD-10 indication, or has contradictory instructions (e.g., ordering an MSLT without an preceding PSG), the technician must not guess or proceed. The technologist must contact the ordering provider or sleep center medical director to obtain a corrected, signed order before testing.

---

3. Patient Contraindications & Clinical Safety Screening

Patient safety requires screening for acute medical conditions that may endanger the patient during an unattended or semi-attended overnight sleep study.

+-----------------------------------------------------------------------------+
|                        PSG CONTRAINDICATION SCREENING                       |
|                                                                             |
|   ABSOLUTE CONTRAINDICATIONS (Reschedule / Direct to Acute Care)            |
|   - Acute unstable cardiac conditions (unstable angina, acute MI, VT/VF)   |
|   - Severe, acute respiratory distress (decompensated COPD, acute asthma)   |
|   - Acute infectious communicable diseases (active open TB, acute COVID-19) |
|   - Uncontrolled, active status epilepticus                                 |
|   - Acute severe intoxication (alcohol/illicit substances posing coma risk) |
|                                                                             |
|   RELATIVE CONTRAINDICATIONS (Require Medical Clearance / Accommodations)   |
|   - Severe claustrophobia (pre-study desensitization required)              |
|   - Recent nasal/facial surgery (may preclude nasal cannula or CPAP mask)   |
|   - Uncontrolled pain or acute illness (fever, gastrointestinal distress)   |
|   - Fragile or severely broken skin at electrode attachment sites           |
+-----------------------------------------------------------------------------+

---

4. Specialized Patient Accommodations

Sleep technologists frequently care for vulnerable patient populations requiring tailored clinical setups and customized monitoring strategies:

1. Mobility and Fall Risk Patients:

   • Identify patients requiring assistance with transfers (wheelchair, walker, crutches).
   • Ensure accessible low-profile beds, locking wheel mechanisms, clear egress pathways free of trailing wires, and bedside call buttons within immediate reach.
   • Never leave a high-fall-risk patient unattended during bathroom breaks; disconnect headbox quick-release cables safely.

2. Cognitive Impairment & Dementia:

   • Permit a familiar family member or authorized caregiver to stay in the room if permitted by facility policy to reduce nighttime delirium and agitation.
   • Utilize gentle, repeated verbal reassurance, secure electrode wiring behind the patient's clothing with tubular netting (Surgilast), and avoid alarming technical jargon.

3. Pediatric Patients:

   • Mandatory presence of a parent or legal guardian throughout the entire testing period.
   • Utilize pediatric-sized sensors (smaller nasal prongs, appropriately sized pediatric RIP effort belts, pediatric pulse oximeter probes).
   • Incorporate End-Tidal $CO_2$ ($EtCO_2$) or Transcutaneous $CO_2$ ($TcCO_2$) capnography monitoring, which is an AASM mandatory standard for pediatric polysomnography.

4. Bariatric Patients:

   • Ensure specialized bariatric beds and armchairs rated for extreme patient weight (typically >400–500 lbs).
   • Provide extended electrode lead wires and extra-large respiratory effort belts to prevent sensor displacement during position changes.
   • Position the patient with the head of the bed slightly elevated if severe orthopnea is present during awake setup.